Gastric ulcer, Duodenal ulcer
Conditions
Interventions
investigational material(s)
Generic name etc : Pariet
INN of investigational material : Rabeprazole Sodium
Therapeutic category code : 232 Agents for peptic ulcer
Dosage and Administration for Investi
Sponsors
Eisai Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients taking long-term low-dose aspirin for prevention of thrombus/embolism at the start of administration of rabeprazole(including patients who start low-dose aspirin on the same day as the start of administration of rabeprazole) (2)Patients with a history of gastric/duodenal ulcers (3)Patients requiring long-term use of rabeprazole for prevention of recurrence of gastric/duodenal ulcers induced by low-dose aspirin
Exclusion criteria
Exclusion criteria: (1)Patients with gastric/duodenal ulcers at the start of administration of rabeprazole (2)Patients with active upper gastrointestinal bleeding at the start of administration of rabeprazole (3)Patients with contraindication for rabeprazole
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse drug reactions Confirm of adverse drug reactions | — |
Outcome results
None listed